Nyxoah S.A (NYXH) | Stock Overview & Key Data
Nyxoah S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €30.00 on July 12, 2021
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nyxoah S.A
NYXH
|
124.00M Small-cap | -1.41% | -45.74% | -48.53% | -66.51% | -65.85% | -79.11% | -80.08% | -94.34% | -92.77% | -92.77% | -92.77% |
| N/A | -1.22% | 14.47% | 5.09% | 6.07% | 7.58% | 85.71% | 225.88% | 200.37% | 364.29% | 681.77% | 681.77% | |
|
UCB S.A
UCB
|
50.14B Large-cap | -0.69% | 9.37% | 1.69% | 8.86% | 10.67% | 68.19% | 220.47% | 222.73% | 332.23% | 618.13% | 618.13% |
|
Argenx SE
ARGX
|
41.43B Large-cap | -0.26% | 9.81% | 24.18% | 24.18% | 24.18% | 29.01% | 29.01% | 29.01% | 29.01% | 29.01% | 29.01% |
|
Fagron NV
FAGR
|
1.73B Large-cap | 2.31% | 0.00% | 11.19% | 17.92% | 11.95% | 13.01% | 57.64% | 25.06% | 247.12% | 93.51% | 93.51% |
|
Ion Beam
IBAB
|
411.94M Mid-cap | -0.25% | 11.42% | 12.66% | 35.68% | 25.00% | 38.30% | 1.44% | 0.00% | -56.09% | 275.56% | 275.56% |
Calculate Your Nyxoah S.A Investment Returns
Long-Term Investment Performance Analysis
Nyxoah S.A stock price in Sep 2020 was €19.50, A €1,000.00 lump sum investment in Nyxoah S.A made 5 years ago would be worth approximately €71.79 today, representing a negative return of -92.82%. This translates to an annualized return (CAGR) of -36.75%.
5 Years 9 Months Investment Scenario (Sep 2020 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is NYXH's 52-week high and low?
- In the last 52 weeks, Nyxoah S.A reached a high of €8.87 (on August 11, 2025) and a low of €1.26 (on June 11, 2026).
- What is the market cap and P/E ratio for NYXH?
- Curious about Nyxoah S.A's size and valuation? Its market capitalization stands at 124.00M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does NYXH pay dividends? If so, what's the yield?
- As for dividends, Nyxoah S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Nyxoah S.A's main competitors or similar companies to consider before investing?
When looking at Nyxoah S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Financière de Tubize
TUBN/A Healthcare Biotechnology 85.71% 225.88% UCB S.A
UCB50.14B Healthcare Biotechnology 68.19% 220.47% Argenx SE
ARGX41.43B Healthcare Biotechnology 29.01% 29.01% Fagron NV
FAGR1.73B Healthcare Drug Manufacturers - Specialty & Generic 13.01% 57.64% Ion Beam
IBAB411.94M Healthcare Medical Devices 38.30% 1.44% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Nyxoah S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Nyxoah S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for NYXH?
- Looking at Nyxoah S.A's growth, its revenue over the trailing twelve months (TTM) was N/A. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of NYXH stock is held by insiders and institutions?
- Wondering who owns Nyxoah S.A stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.